J9210 – Injection, emapalumab-lzsg, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9210
- Long description
- Injection, emapalumab-lzsg, 1 mg
- Short description
- Inj., emapalumab-lzsg, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2019
- Last change
- October 1, 2019 – No change
Frequently asked questions
What is HCPCS code J9210?
J9210 is a HCPCS Level II code for injection, emapalumab-lzsg, 1 mg.
Does Medicare cover J9210?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9202 – Goserelin acetate implant, per 3.6 mg
- J9203 – Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 – Injection, mogamulizumab-kpkc, 1 mg
- J9205 – Injection, irinotecan liposome, 1 mg
- J9206 – Injection, irinotecan, 20 mg
- J9207 – Injection, ixabepilone, 1 mg
- J9208 – Injection, ifosfamide, 1 gram
- J9209 – Injection, mesna, 200 mg
- J9211 – Injection, idarubicin hydrochloride, 5 mg
- J9212 – Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213 – Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214 – Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215 – Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
- J9216 – Injection, interferon, gamma 1-b, 3 million units
- J9217 – Leuprolide acetate (for depot suspension), 7.5 mg
- J9218 – Leuprolide acetate, per 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.